Article contents
Legal Regulation of the Use of Race in Medical Research
Published online by Cambridge University Press: 01 January 2021
Extract
We have previously addressed the use of race in health care generally. Subsequent developments have made the issue even more pointed. Given the recent Food and Drug Administration (FDA) approval of BiDil as a result of a clinical trial limited to participants identifying themselves as African-American, this Symposium could not be more timely as an effort to further advance the dialogue on the issue of race in medical research. While this dialogue has informed our own analysis, we believe our distinctive contribution concerns the extent to which the law does and should constrain such use of race. Even in legal academic circles – somewhat notorious for considering problems of little practical significance – the issue has been given little thought. This piece, therefore, attempts to analyze extant legal regimes against the backdrop of medical and scientific developments.
- Type
- Symposium
- Information
- Copyright
- Copyright © American Society of Law, Medicine and Ethics 2006
References
- 9
- Cited by